Actively Recruiting

Age: 18Years +
All Genders
ID06591702

Investigation of the Validity, Reliability, and Responsiveness of BETY-Biopsychosocial Questionnaire in Individuals with Chronic Kidney Disease, on Dialysis, and Kidney Transplantation

Led by Hacettepe University · Updated on 2024-09-19

150

Participants Needed

1

Research Sites

44 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Chronic Kidney Disease (CKD) is linked to significant psychosocial challenges such as depression, anxiety, and reduced quality of life. Understanding the biopsychosocial aspects of CKD can help improve disease management. This research evaluates the BETY-Biopsychosocial Questionnaire (BETY-BQ), a tool designed to assess physical, emotional, and social factors in patients with CKD, including those on dialysis and kidney transplant recipients, to support better care and outcomes. The study involves applying the BETY-BQ to individuals diagnosed with CKD, those undergoing dialysis, and kidney transplant recipients. This questionnaire, developed from an innovative exercise therapy model, assesses multiple biopsychosocial characteristics like pain, mood, functionality, sociability, sexuality, and sleep. The research aims to validate the BETY-BQ's reliability, validity, and sensitivity in this patient group by collecting questionnaire data over three months. Participants will complete the BETY-BQ and other assessments such as the Hospital Anxiety Depression Scale, Kidney Disease and Quality of Life (KDQOL-36), Clinical Frailty Scale, and Frail Scale over three months. These evaluations help researchers understand the psychosocial impact of CKD and related treatments. The study is observational, with no drug or treatment interventions, and participants will contribute data to help verify the questionnaire as a useful tool for healthcare teams managing CKD.

CONDITIONS

Brief Title

Investigation of the Validity, Reliability, and Responsiveness of BETY-BQ in Chronic Kidney Disease, on Dialysis, and Kidney Transplantation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with chronic kidney disease
  • Age 18 years or older
  • Provided consent to participate
  • Being a dialysis patient (for dialysis group)
  • Having had a kidney transplant (for transplant group)
Not Eligible

You will not qualify if you...

  • Having an acute infection
  • Diagnosed with cancer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 3 months

Participants complete questionnaires to assess biopsychosocial factors, anxiety, depression, quality of life, and frailty related to chronic kidney disease, dialysis, or kidney transplantation.

1 baseline visit and 1 follow-up visit

Trial Site Locations

Total: 1 location

1

Hacettepe University

Ankara, Altındağ, Turkey (Türkiye), 06100

Actively Recruiting

Loading map...

Research Team

O

Orkun Tüfekçi, PT, PhD (c)

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Biomarker-targeted Clinical Trial to Optimize Treatment fo...

Chronic Kidney Disease(CKD)

Actively Recruiting

4 locations

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Stu...

Hyperphosphatemia

Actively Recruiting

26 locations

A Randomized, Double-blind, Placebo-controlled Study to Eval...

Chronic Kidney Disease(CKD)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here